{"id":8507,"date":"2022-03-29T12:41:04","date_gmt":"2022-03-29T12:41:04","guid":{"rendered":"https:\/\/live-cancer-factfinder.pantheonsite.io\/fact-finder-tool\/grenn-kontraseptif\/"},"modified":"2026-10-20T15:53:43","modified_gmt":"2026-10-20T15:53:43","slug":"grenn-kontraseptif","status":"publish","type":"post","link":"https:\/\/cancerfactfinder.org\/ht\/zouti-pou-cheche-enfomasyon\/grenn-kontraseptif\/","title":{"rendered":"AFIKASYON: Pil kontraseptif yo lak\u00f2z kans\u00e8"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Sa ou ka tande<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Moun ki pran grenn kontraseptif gen plis risk pou yo gen kans\u00e8.  <\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"what-science-tells-us\">Sa syans di nou<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Pil kontraseptif yo itilize pou anpeche gwos\u00e8s epi yo gen de \u00f2m\u00f2n: estwoj\u00e8n ak pwojestew\u00f2n ki ede regle sik r\u00e8g la (<\/span> <a href=\"https:\/\/my.clevelandclinic.org\/health\/drugs\/3977-birth-control-the-pill\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Cleveland Clinic<\/span><\/a> <span style=\"font-weight: 400;\">). Pil kontraseptif yo anpeche gwos\u00e8s l\u00e8 yo sispann ovilasyon epi anpeche esp\u00e8m penetre nan k\u00f2l matris la. Kalite kontraseptif oral ki pi souvan preskri a souvan refere yo k\u00f2m tou senpleman &#8220;grenn&#8221; oswa pafwa &#8220;kontrasepsyon&#8221; Ozetazini.<\/span><\/p>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Epidemyolojik<\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Pr\u00e8v yo sou grenn kontraseptif ak kans\u00e8 yo melanje, sa depann de kalite kans\u00e8 a: kontraseptif oral yo ogmante risk pou kans\u00e8 nan tete ak nan k\u00f2l matris yon ti kras, men yo diminye risk pou kans\u00e8 nan andometry\u00f2m, nan ov\u00e8 ak nan kolon.<\/span><\/p>\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Tete: Fanm ki te deja itilize kontraseptif oral yo gen yon ti ogmantasyon (7%) konpare ak fanm ki pa janm itilize kontraseptif oral. Fanm k ap itilize kontraseptif oral kounye a gen yon ogmantasyon 24% nan risk. Risk pou kans\u00e8 nan tete ogmante tou plis moun ap itilize kontraseptif oral pou yon tan (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones\/oral-contraceptives-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">K\u00f2l matris: Fanm ki itilize kontraseptif oral pandan 5 an oswa plis gen plis risk pou yo gen kans\u00e8 nan k\u00f2l matris pase fanm ki pa janm itilize grenn kontraseptif. Plis yon fanm itilize kontraseptif oral, se plis risk li genyen pou l gen kans\u00e8 nan k\u00f2l matris (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones\/oral-contraceptives-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Andometriyal (Uterin): Fanm ki te deja itilize kontraseptif oral gen yon risk 30% mwens pou yo gen kans\u00e8 andometriyal (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones\/oral-contraceptives-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">). Ef\u00e8 pwoteksyon sa a kontinye pandan plizy\u00e8 ane apre fanm nan sispann itilize kontraseptif oral.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ov\u00e8: Itilizasyon kontraseptif oral bay yon risk 30-50% mwens pou kans\u00e8 nan ov\u00e8 pase fanm ki pa janm itilize kontraseptif oral (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones\/oral-contraceptives-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">). Pwoteksyon sa a ogmante ak dire tan yo itilize kontraseptif oral yo.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kolon\u00e8ktal: Kontraseptif oral yo diminye risk kans\u00e8 kolorektal pa 15% a 20% (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones\/oral-contraceptives-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Laboratwa\/Pr\u00e8v Sip\u00f2<\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Ekspozisyon a \u00f2m\u00f2n nan etid laboratwa ak sou b\u00e8t gen ef\u00e8 sou selil ak tisi ki jeneralman konsistan av\u00e8k pr\u00e8v epidemyolojik yo.  <\/span><\/p>\n\n<h3 class=\"wp-block-heading\">Klasifikasyon kanseroj\u00e8n IARC:<span style=\"font-weight: 400;\"> <\/span><\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Gwoup 1 (Kanseroj\u00e8n pou Moun)<\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"how-to-reduce-your-risk\">Kijan pou diminye risk ou<\/h2>\n\n<p class=\"wp-block-paragraph\">Pale ak dokt\u00e8 w sou tout opsyon kontraseptif yo ak risk potansy\u00e8l yo anvan w pran yon desizyon. Laj ou, pwa w, istwa repwodiktif ou, ak istwa familyal ou ka mete w an risk pou w gen k\u00e8k kans\u00e8 jinekolojik. Pil kontraseptif yo ka mete fanm yo an plis risk pou yo gen l\u00f2t pwobl\u00e8m sante, tankou boul nan san, maladi k\u00e8, ak konjesyon serebral ( <a href=\"https:\/\/www.mdanderson.org\/publications\/focused-on-health\/birth-control-pill-and-cancer-risk.h28Z1590624.html\" target=\"_blank\" rel=\"noopener\">MD Anderson<\/a> ).  <br\/><\/p>\n\n<p class=\"wp-block-paragraph\">Gen pi gwo fakt\u00e8 risk kans\u00e8 pase kontraseptif oral yo. Pa egzanp, plis ka kans\u00e8 nan k\u00f2l matris ki koze pa papillomavirus imen an (HPV) pase l\u00e8 w ap pran grenn kontraseptif, epi plis ka kans\u00e8 nan tete ki koze pa move rejim alimant\u00e8 ak nivo aktivite fizik ki ba pase kontraseptif oral yo ( <a href=\"https:\/\/www.mdanderson.org\/publications\/focused-on-health\/birth-control-pill-and-cancer-risk.h28Z1590624.html\" target=\"_blank\" rel=\"noopener\">MD Anderson<\/a> ). <br\/><\/p>\n\n<p class=\"wp-block-paragraph\">Finalman, gen anpil l\u00f2t opsyon kontraseptif ki pa afekte risk kans\u00e8 a. Pa egzanp, apar\u00e8y entrauterin ki pa ormonal (DIU) yo se ti apar\u00e8y metal oswa plastik ke yon jinekol\u00f2g mete nan matris la pou anpeche gwos\u00e8s ( <a href=\"https:\/\/www.mskcc.org\/news\/birth-control-and-cancer-risk\" target=\"_blank\" rel=\"noopener\">MSK<\/a> ). <\/p>\n\n<h2 class=\"wp-block-heading\" id=\"bottom-line\">Liy final la<\/h2>\n\n<p class=\"wp-block-paragraph\">Kontraseptif oral yo ogmante yon ti kras risk pou kans\u00e8 nan tete ak nan k\u00f2l matris, men yo diminye risk pou kans\u00e8 nan andometry\u00f2m, nan ov\u00e8 ak nan kolon. Pale ak dokt\u00e8 w pou w jwenn pi bon kontrasepsyon pou ou. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sa ou ka tande Moun ki pran grenn kontraseptif gen plis risk pou yo gen kans\u00e8. Sa syans di nou Pil kontraseptif yo itilize pou anpeche gwos\u00e8s epi yo gen de \u00f2m\u00f2n: estwoj\u00e8n ak pwojestew\u00f2n ki ede regle sik r\u00e8g la ( Cleveland Clinic ). Pil kontraseptif yo anpeche gwos\u00e8s l\u00e8 yo sispann ovilasyon epi&hellip;<\/p>\n","protected":false},"author":1,"featured_media":8509,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[522],"tags":[472],"class_list":["post-8507","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pwoblem-medikal-oswa-tretman","tag-definitivman-oswa-pwobableman-vre"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=8507"}],"version-history":[{"count":8,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8507\/revisions"}],"predecessor-version":[{"id":13830,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8507\/revisions\/13830"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/8509"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=8507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=8507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=8507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}